Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification and Performance Verification of Analytical Balances – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification and Performance Verification of Analytical Balances – V 2.0

Standard Operating Procedure for Qualification and Performance Verification of Analytical Balances in AMD


Department Analytical Method Development
SOP No. SOP/AMD/316/2025
Supersedes SOP/AMD/316/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to outline the qualification process and periodic performance verification procedures for analytical balances to ensure they provide accurate, consistent, and

reliable weight measurements as per GMP and ICH guidelines.

2. Scope

This SOP applies to all analytical balances used within the Analytical Method Development (AMD) department for sample and standard preparation requiring high precision weighing.

3. Responsibilities

  • Analytical Chemist: Performs daily checks, qualification support, and documents readings.
  • Engineering/Maintenance: Provides technical support during installation qualification and preventive maintenance.
  • QA Personnel: Verifies qualification documents and ensures protocol compliance.
See also  Analytical Method Development: HPLC Method Development for Finished Product - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that all analytical balances undergo proper qualification and periodic verification in accordance with the approved schedule and regulatory expectations.

5. Procedure

5.1 Qualification Phases

  1. Installation Qualification (IQ):
    • Ensure placement on vibration-free surface in a controlled environment.
    • Verify calibration certificates from manufacturer.
    • Connect instrument to stable power source with proper grounding.
  2. Operational Qualification (OQ):
    • Test linearity using certified standard weights (e.g., 1 mg to 200 g).
    • Conduct repeatability and drift checks by weighing same mass multiple times.
    • Verify leveling, display resolution, and functionality of tare/zero buttons.
  3. Performance Qualification (PQ):
    • Evaluate routine use conditions with typical loads.
    • Verify performance over extended weighing cycles.
    • Include environmental monitoring during PQ (temperature/humidity).

5.2 Daily Performance Verification

  1. Verify balance leveling using built-in indicators.
  2. Record balance ID, date, time, and weight readings in logbook (Annexure-1).
  3. Use certified weights (e.g., 10 mg, 100 mg, 1 g, 10 g) traceable to NABL/NIST standards.
  4. Perform weighing in triplicate and document average deviation and % error.
See also  Analytical Method Development: SOP for Nanoformulations Analysis Method - V 2.0

5.3 Acceptance Criteria

  1. Repeatability: RSD should be ≤ 0.1% for five consecutive measurements.
  2. Accuracy: Weight difference should not exceed ±0.1 mg for weights ≤ 20 g, and ±0.2 mg for weights above 20 g.

5.4 Preventive Maintenance and Re-Qualification

  1. Conduct preventive maintenance every 6 months or as per manufacturer guidance.
  2. Post-maintenance, perform full OQ and PQ before resuming analytical use.

5.5 Deviation Handling

  1. Record any failed results in the deviation log (Annexure-2).
  2. Initiate root cause analysis and implement CAPA measures.
  3. Do not use the balance until successful re-verification is completed.

6. Abbreviations

  • IQ: Installation Qualification
  • OQ: Operational Qualification
  • PQ: Performance Qualification
  • RSD: Relative Standard Deviation
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Balance Qualification Protocol – Annexure-1
  2. Daily Performance Log – Annexure-2
  3. Deviation & CAPA Register – Annexure-3

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP Chapter <41> Weights and Balances
  • 21 CFR Part 211 – GMP Requirements
  • GAMP5 – Good Automated Manufacturing Practice
See also  Analytical Method Development: SOP for Qualification of Receiving Laboratory - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Vikram Joshi Anita Shah Dr. Harshita Goyal
Designation Analyst – AMD QA Reviewer Department Head
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Balance Qualification Protocol

Includes sections for IQ, OQ, and PQ with checklists, observations, and sign-offs.

Annexure-2: Daily Performance Log

Date Balance ID Weight Used Reading 1 Reading 2 Reading 3 Avg RSD (%) Status
01/06/2025 BL-102 100 mg 100.003 100.002 100.001 100.002 0.001 Pass

Annexure-3: Deviation & CAPA Register

Logs any failure, deviation number, description, root cause, corrective actions, and final verification status.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Added PQ verification and updated accuracy criteria Annual Review Dr. Harshita Goyal
12/08/2022 1.0 Initial SOP Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0
Next Post: Elixir Department: SOP for Compatibility Testing with Containers – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version